Welcome
Support Centre
19 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Fermentation and cardiovascular risk factors
ISRCTN ISRCTN35312139
ClinicalTrials.gov identifier
Public title Fermentation and cardiovascular risk factors
Scientific title
Acronym N/A
Serial number at source NS1
Study hypothesis That consuming a fermentable carbohydrate will improve indices of insulin sensitivity in individuals with insulin resistance.
Ethics approval Central Office of Research Ethics Committees (COREC) and the University of Surrey Ethics Committee, approved on 26th June 2006 (REC ref: O6/Q1909/30)
Study design Randomised, parallel, single-blind dietary intervention.
Countries of recruitment United Kingdom
Disease/condition/study domain Type 2 diabetes/ obesity
Participants - inclusion criteria 1. Healthy
2. Fasting insulin >60 pmol/l
2. Male and female 18-60 years
Participants - exclusion criteria 1. Cardiovascular or endocrine diseases
2. Medication likely to affects either lipid or glucose metabolism
Anticipated start date 01/11/2006
Anticipated end date 30/10/2008
Status of trial Completed
Patient information material
Target number of participants 45
Interventions Dietary supplementation with either 0 g, 20 g or 40 g resistant starch per day for 12 weeks.
Primary outcome measure(s) Insulin sensitivity will be assessed before and after the 12-week intervention by the following:
1. Euglycaemic-hyperinsulinaemic clamp
2. Liver fat content measured by Magnetic Resonance Imaging [MRI]
Secondary outcome measure(s) The following outcomes are being measured before and after the 12-week intervention:
1. Endothelial function, assessed by Pulse Wave Velocity (PWV) and 24-hour blood pressure recordings
2. Blood inflammatory markers
Sources of funding National Starch and Chemical Company (International)
Trial website
Publications
Contact name Dr  Denise  Robertson
  Address Biomedical and Molecular Sciences
University of Surrey
  City/town Guildford
  Zip/Postcode GU2 7XH
  Country United Kingdom
Sponsor University of Surrey (UK)
  Address Research and Enterprise Support
Nodus Centre
University of Surrey
  City/town Guildford
  Zip/Postcode GU2 7XH
  Country United Kingdom
  Sponsor website: http://www.surrey.ac.uk/
Date applied 07/06/2007
Last edited 02/08/2007
Date ISRCTN assigned 02/08/2007
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central